{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-007938","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.365232+00:00","generated_at":"2026-06-17T16:03:36.551814+00:00","sec_items":["1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioLargo extends CFO Charles Dargan's engagement through Jan 2024; grants option for 300,000 shares","bullets":["CFO Charles K. Dargan II's engagement extended one year to January 31, 2024.","Compensation: option to purchase 300,000 shares of common stock at $0.20/share.","Option vests monthly (25,000 shares/month) starting March 21, 2023; expires in 10 years.","No cash compensation; CFO eligible for business expense reimbursement (historically not requested).","Prior extension expired January 31, 2023; agreement may be terminated on 30 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-007938","json":"https://secwatch.observer/filing/0001437749-23-007938.json","markdown":"https://secwatch.observer/filing/0001437749-23-007938.md","text":"https://secwatch.observer/filing/0001437749-23-007938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774923007938/0001437749-23-007938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774923007938/blgo20230322_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:03:36.551814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}